The landscape of clinical mycology is constantly changing. New therapies for malignant and
autoimmune diseases have led to new risk factors for unusual mycoses. Invasive …

Histoplasmosis is a global disease endemic to regions of all six inhabited continents. The
areas of highest endemicity lie within the Mississippi and Ohio River Valleys of North …

Background Histoplasmosis is a chronic granulomatous disease caused by the thermally
dimorphic fungus Histoplasma capsulatum. The 2 variants Histoplasma capsulatum var …

Histoplasmosis is a serious infectious disease in humans caused by Histoplasma
spp.(Onygenales), whose natural reservoirs are thought to be soil enriched with bird and bat …

Invasive fungal diseases (IFDs) are of huge concern in resource-limited settings, particularly
in Africa, due to the unavailability of diagnostic armamentarium for IFDs, thus making …

Abstract Background Histoplasmosis caused by Histoplasma capsulatum var. duboisii (Hcd)
is a rare, but probably underestimated, endemic infection described in intertropical Africa …

Histoplasmosis, tuberculosis and HIV are all highly prevalent in sub-Saharan Africa (SSA).
Co-occurrence of two or more of these infections has been reported in several populations …

Most of the reviews on histoplasmosis documented in literature have been in the adult
population. Very few studies highlight the peculiarities associated with histoplasmosis in …

The classification of histoplasmosis as an AIDS-defining illness has largely attributed its
occurrence in people to the presence of HIV/AIDS especially in Africa. Prior to the advent of …

The Republic of Congo (RoC) is one of the African countries with the most histoplasmosis
cases reported. This review summarizes the current status regarding epidemiology …